Evidence map›Paper›PMID 38967905›Full record

ReviewMolecular neurobiology2025

The Role of the Neural Exposome as a Novel Strategy to Identify and Mitigate Health Inequities in Alzheimer's Disease and Related Dementias.

Ravid Granov, Skyler Vedad, Shu-Han Wang, Andrea Durham, Divyash Shah, Giulio Maria Pasinetti

Abstract readReview
In one paragraph

Review in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Driving the neural exposome: Latent mobility states from naturalistic GPS data in older adults.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ravid Granov *Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10019, USA.
Skyler Vedad *Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10019, USA.
Shu-Han Wang *Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10019, USA.
Andrea Durham *Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10019, USA.
Divyash ShahDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10019, USA.
Giulio Maria PasinettiDepartment of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, 10019, USA. giulio.pasinetti@mssm.edu.

Funding

BLRD VA I01 BX005054U.S. Department of Veterans Affairs (VA) BX0005054
6 · The paper itself

Abstract

With the continuous increase of the elderly population, there is an urgency to understand and develop relevant treatments for Alzheimer's disease and related dementias (ADRD). In tandem with this, the prevalence of health inequities continues to rise as disadvantaged communities fail to be included in mainstream research. The neural exposome poses as a relevant mechanistic approach and tool for investigating ADRD onset, progression, and pathology as it accounts for several different factors: exogenous, endogenous, and behavioral. Consequently, through the neural exposome, health inequities can be addressed in ADRD research. In this paper, we address how the neural exposome relates to ADRD by contributing to the discourse through defining how the neural exposome can be developed as a tool in accordance with machine learning. Through this, machine learning can allow for developing a greater insight into the application of transferring and making sense of experimental mouse models exposed to health inequities and potentially relate it to humans. The overall goal moving beyond this paper is to define a multitude of potential factors that can increase the risk of ADRD onset and integrate them to create an interdisciplinary approach to the study of ADRD and subsequently translate the findings to clinical research.

Indexed as

Alzheimer DiseaseExposomeAnimalsDementiaHumansMachine LearningAlzheimer’s diseaseArtificial intelligenceMachine learningNeural exposomeRisk factors

Identifiers

PMID38967905
PMCPMC11711138

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.